Milestone Pharmaceuticals Inc’s (NASDAQ: MIST) Stock’s Potential for Future Price Increase

In the last trading session, 1.04 million Milestone Pharmaceuticals Inc (NASDAQ:MIST) shares changed hands as the company’s beta touched 0.80. With the company’s per share price at $1.29 changed hands at $0.07 or 5.74% during last session, the market valuation stood at $68.97M. MIST’s last price was a discount, traded about -113.18% off its 52-week high of $2.75. The share price had its 52-week low at $0.63, which suggests the last value was 51.16% up since then.

Analysts gave the Milestone Pharmaceuticals Inc (MIST) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MIST as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.

Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information

Instantly MIST was in green as seen at the end of in last trading. With action 7.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -45.34%, with the 5-day performance at 7.50% in the green. However, in the 30-day time frame, Milestone Pharmaceuticals Inc (NASDAQ:MIST) is 45.12% up.

The consensus price target for the stock as assigned by Wall Street analysts is 10, meaning bulls need an upside of 87.1% from its current market value. According to analyst projections, MIST’s forecast low is 10 with 10 as the target high. To hit the forecast high, the stock’s price needs a -675.19% plunge from its current level, while the stock would need to soar -675.19% for it to hit the projected low.

Milestone Pharmaceuticals Inc (MIST) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 28.21%. The 2025 estimates are for Milestone Pharmaceuticals Inc earnings to decrease by -11.57%, but the outlook for the next 5-year period is at 7.52% per year.

Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders

RTW INVESTMENTS, LP holds the second largest percentage of outstanding shares, with 4.9211% or 3.26 million shares worth $4.3 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF. With 19.87 shares estimated at $25634.0 under it, the former controlled 0.04% of total outstanding shares. On the other hand, SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF held about 0.03% of the shares, roughly 18.54 shares worth around $23912.0.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.